Home / Pharmaceutical company intelligence
CCL Pharmaceuticals (Pvt.) Limited logo
Pharmaceutical company intelligence

CCL Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-headquartered pharmaceutical and healthcare company with manufacturing operations and a multi-country commercial presence.

CCL Pharmaceuticals products in Pakistan

CCL Pharmaceuticals (Pvt.) Limited has 250 medicine presentations registered in Pakistan under 110 brands, covering 98 generic medicines. Most of its products are in Anti-infectives, Hematology & thrombosis and CNS & mental health. Its brands with the most registered strengths and packs are EPICETAM (Levetiracetam), XALIA (Rivaroxaban), CEF-OD (Cefixime) and DASIROX (Deferasirox). 250 products have an official DRAP price on MedInfoBase. See all 110 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Nov 2026Latest source-check date across this published portfolio
Latest effective price date17 Sep 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
65, Quaid-e-Azam Industrial Estate, Kot Lakhpat, Lahore, Pakistan
Phone
+92 42 111 225 678
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000052 CCL Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000052 205 linked products · source seen 13 Nov 2026 View source ↗
DML 000891 40 linked products · source seen 13 Nov 2026 View source ↗
DSL 05-354-0077-068122D 14 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx279public portfolio records represented
REG218unique registrations represented
IDX0indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER115registry-verified exact registrations
PKR250current validated price records
G98generic molecules in indexed catalogue
DF9dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixCCL Pharmaceuticals (Pvt.) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Anti-infectives78 · 31%Hematology & thrombosis33 · 13%CNS & mental health32 · 13%Oncology & immunology29 · 12%Cardiovascular28 · 11%Vitamins, minerals & nutrition20 · 8%Gastrointestinal & hepatology15 · 6%Other therapeutic areas15 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioCCL Pharmaceuticals (Pvt.) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026250presentationsTablet138 · 55%Injection44 · 18%Capsule26 · 10%Cream11 · 4%Syrup11 · 4%Suspension10 · 4%Other forms10 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionCCL Pharmaceuticals (Pvt.) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026218comparable productsBelow peer median27 · 12%Near peer median75 · 34%Above peer median116 · 53%Company median price position+5.6%Lowest-price equivalents14Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsCCL Pharmaceuticals (Pvt.) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/ccl-pharmaceuticals-pvt-ltdGenerated 13 Nov 2026Nabiqasim Industries (Pvt) Ltd.,49 shared50% overlapM/s. Genix Pharma (Pvt) Ltd.44 shared45% overlapPharmasol (Pvt) Ltd.44 shared45% overlapGenome Pharmaceuticals (Pvt.) Ltd.43 shared44% overlapHIGH-Q Pharmaceuticals42 shared43% overlapBio-Labs(Pvt) Ltd40 shared41% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet138 products
Injection44 products
Capsule26 products
Cream11 products
Syrup11 products
Suspension10 products
Infusion5 products
Lotion3 products
Other2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where CCL Pharmaceuticals (Pvt.) Limited is priced against the market

218 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers192Distinct registrations among indexed, published, presentation-validated products only
Verified price observations250
Products with a verified price250
Products with multiple price observations0
Source records with multiple versions249
Latest portfolio source check12 Nov 2026
Latest effective price date17 Sep 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

218 unique registration(s) · 0 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
No matching products.
A to Z

All 110 CCL Pharmaceuticals brands in Pakistan

  • ABRIVA Sofosbuvir · 400 mg tablet
  • ABRIVA PLUS Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
  • ACASIA Azithromycin · 250 mg capsule
  • AMID Amiodarone · 100 mg tablet, 200 mg tablet
  • ARYOTRUST Trastuzumab · 150 mg injection
  • ASPEC Acetylsalicylic acid (Aspirin) · 150 mg tablet, 300 mg tablet, 75 mg tablet
  • BACTCID Ciprofloxacin · 100 mg injection, 250 mg tablet, 250 mg/5 mL suspension
  • BISOLOL Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet
  • BUPRON Bupropion · 150 mg tablet
  • CEF-OD Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 400 mg capsule
  • CEF-OD DS Cefixime · 200 mg/5 mL suspension
  • CEFTORINGE Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • CLYSO Cycloserine · 250 mg capsule
  • COMBIVIRIN Lamivudine + Zidovudine · 150 mg + 300 mg tablet
  • COMFER Iron, Iron polymaltose complex · 50 mg/5 mL syrup
  • CRICHRIAZ Ascorbic acid · 500 mg tablet
  • CYOTECAN Irinotecan · 40 mg injection
  • CYTOTECAN Irinotecan · 100 mg/5 mL injection
  • DANSET Ondansetron · 8 mg tablet
  • DASIROX Deferasirox · 100 mg tablet, 250 mg tablet, 400 mg tablet
  • DIAMET Metformin · 1 g tablet, 500 MG tablet, 850 mg tablet
  • DILCOZYME Pepsin + Papain + Vitamin B1 + Vitamin B6 + Vitamin B2 + Vitamin B12 + Nicotinamide + Calcium pantothenate · 50 mg + 50 mg + 5 mg + 2 mg + 2 mg + 5 mcg + 20 mg + 1 mg/5 mL syrup
  • DOXOCIN Doxorubicin · 10 mg injection, 50 mg injection
  • DULAC Lactulose · 3.35 g/5 mL syrup
  • Dyamide Loperamide HCl · 2 mg capsule
  • Dyazol Letrozole · 2.5 mg tablet
  • Dyflex Fluoxetine · 20 mg capsule
  • Dynaclo Clotrimazole · 1% lotion
  • Dynamycin Azithromycin · 250 mg tablet, 250 mg capsule, 500 mg tablet
  • Dynarix Permethrin · 5% cream
  • Dynasil Terbinafine · 1 % cream
  • Dynatrim Clotrimazole · 1% cream, 10% cream
  • Dynatrim Extra Clotrimazole + Hydrocortisone · 1% + 1% cream
  • Dynazin Silver sulfadiazine · 1 % cream, 1% cream
  • Dynovate Betamethasone valerate, Betamethasone · 0.1 % lotion, 0.1% cream
  • Dyphin Clomifene citrate · 50 mg tablet
  • Dyvol Divalproex sodium · 250 mg tablet, 500 mg tablet
  • EPICETAM Levetiracetam · 1000 mg tablet, 250 mg tablet, 500 mg injection
  • EPIPRO Divalproex sodium · 250 mg tablet, 500 mg tablet
  • EPO Epoetin (recombinant human erythropoietin) · 2000 IU injection
  • FAAST Omeprazole, Omeprazole enteric coated pellets · 20 mg capsule, 40 mg capsule
  • Fluxet Fluoxetine · 20 mg capsule
  • GEMMIN Gemcitabine · 1 g injection, 200 Mg injection
  • HONGOS Voriconazole · 200 mg/5 mL suspension
  • Hulac liquid Lactulose · 3.3 g/5 mL oral liquid
  • IOCAB Potassium iodide · 130 mg tablet, 65 mg tablet
  • ISOR Isosorbide dinitrate · 10 mg tablet, 20 mg tablet, 5 mg tablet
  • JARDY Empagliflozin · 10 mg tablet, 25 mg tablet
  • Jarzem Empagliflozin · 10 mg tablet, 25 mg tablet
  • LAMITRA Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
  • Lecetam Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • LEUCOFOLATE Calcium folinate (folinic acid) · 100 mg injection, 15 mg injection, 50 mg injection
  • Leukozole Fluconazole · 150 mg capsule, 50 mg capsule
  • LEVOCIL Levofloxacin · 250 mg tablet, 500 mg tablet
  • LOSIRAL Letrozole · 2.5 mg tablet
  • LYMPHOSIDE Etoposide · 100 mg injection
  • MALGO Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 40 mg injection, 40 mg + 240 mg tablet
  • MALGO 80/480 Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • MATRIP Sumatriptan · 25 mg tablet, 50 mg tablet
  • MAXIVIR Lamivudine · 100 mg tablet
  • MEBREXEL Docetaxel · 20 mg injection, 80 mg injection
  • METAPLAXEL Paclitaxel, Paclitaxel (albumin-bound nanoparticles) · 150 mg/25 mL injection, 30 mg/5 mL injection
  • METOMIDE Metoclopramide · 10 mg tablet, 10 mg/2 mL injection
  • MOLOX Moxifloxacin · 400 mg tablet
  • MYCOLE Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
  • NEO-KLAR Clarithromycin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
  • NEO-KLAR SR Clarithromycin · 500 mg tablet
  • NOCLOT Clopidogrel · 75 mg tablet
  • NOCLOT-EA Clopidogrel + Aspirin · 75 mg + 150 mg tablet, 75 mg + 75 mg tablet
  • Noclot-LD 300 Clopidogrel · 300 mg tablet
  • NORMOPRESS Losartan · 25 mg tablet, 50 mg tablet
  • NORMOZIDE Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
  • ONCOPLATIN Cisplatin · 50 mg injection
  • ORAVACS Cholera vaccine (inactivated whole-cell + recombinant B-subunit), oral, Oral cholera vaccine · 5 × 10^10 inactivated V. cholerae cells + 1 mg recombinant cholera toxin B-subunit / capsule capsule, 5×10^10 cells + 1 mg rCTB capsule
  • ORFARIN Warfarin · 5 mg tablet
  • PANACEF Ceftazidime · 1 g injection, 250 mg injection
  • PIPBACTA Piperacillin + tazobactam · 2 g + 0.25 g injection
  • RADIAL Linezolid · 2 mg infusion, 400 mg tablet, 600 mg tablet
  • RBJEN Ferric carboxymaltose · 500 mg/10 mL injection, 500 mg/10 mL infusion
  • Riconza Itraconazole · 100 mg capsule
  • RITLO Lopinavir + Ritonavir · 100 mg + 25 mg tablet, 200 mg + 50 mg tablet
  • Rivadyn Rivaroxaban · 10 mg tablet, 2.5 mg tablet
  • Sacodyn Bisacodyl · 5 mg tablet
  • SANRUI Oseltamivir · 30 mg capsule, 75 mg capsule
  • SEZODON Risperidone · 1 mg tablet, 2 mg tablet, 4 MG tablet
  • SIM-STAT Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • SNARE Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Spirodyn Spironolactone · 100 mg tablet, 25 mg tablet
  • STIVANT Bevacizumab · 100 mg injection, 400 mg/16 mL infusion
  • SUCROFER-F Elemental iron + Folic acid, Iron protein succinylate + Folic acid · 20 mg + 2.5 mg tablet, 800 mg iron protein succinylate (equiv. 40 mg elemental iron) + 5 mg folic acid/15 mL syrup, 800 mg/15 mL + 5 mg/15 mL syrup
  • SUCROFER-S Iron protein succinylate · 800 mg/15 mL (equiv. 40 mg elemental iron) syrup, 800 mg/5 mL syrup
  • SUCROFER-T Iron protein succinylate · 400 mg + 20 mg tablet
  • TACAVIR Entecavir · 0.05 mg/mL suspension, 0.5 mg tablet, 1 mg tablet
  • TACGRAF Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
  • TALAM Telmisartan + Amlodipine · 10 mg + 40 mg tablet, 10 mg + 80 mg tablet, 5 mg + 40 mg tablet
  • TALAM 10/40 Telmisartan + Amlodipine · 10 mg + 40 mg tablet
  • TALAM 5/80 Telmisartan + Amlodipine · 5 mg + 80 mg tablet
  • TEGREY Carbamazepine · 100 mg/5 mL suspension
  • TELSARTAN PLUS Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet
  • TENOVIR Tenofovir disoproxil · 300 mg tablet
  • TENSORETIC Lisinopril · 20 mg tablet
  • TOXIPLATIN Carboplatin · 150 mg injection, 450 mg injection
  • UROPHOS Calcium acetate · 667 mg tablet
  • VONAL Voriconazole · 200 mg tablet
  • XALIA Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
  • XALIA 2.5 Rivaroxaban · 2.5 mg tablet
  • XALIPLATIN Oxaliplatin · 100 mg injection, 50 mg injection
  • Xiaquis Apixaban · 5 mg tablet
  • Zihe Zinc · 10 mg tablet, 20 mg tablet
  • Zytux Rituximab · 100 mg injection, 100 mg/10 mL injection, 500 mg/50 mL infusion
Questions

CCL Pharmaceuticals: common questions

How many products does CCL Pharmaceuticals have in Pakistan?

CCL Pharmaceuticals (Pvt.) Limited has 250 registered medicine presentations in Pakistan, sold under 110 brands and covering 98 generic medicines.

What are the main brands of CCL Pharmaceuticals?

By number of registered strengths and packs, its largest brands are EPICETAM (Levetiracetam), XALIA (Rivaroxaban), CEF-OD (Cefixime), DASIROX (Deferasirox) and LEUCOFOLATE (Calcium folinate (folinic acid)). This is not a sales ranking.

Which therapy areas does CCL Pharmaceuticals cover?

The most products are in Anti-infectives (78), Hematology & thrombosis (33), CNS & mental health (32), Oncology & immunology (29) and Cardiovascular (28).

Where can I see CCL Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). CCL Pharmaceuticals (Pvt.) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/ccl-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9